Secukinumab attenuates reactive astrogliosis via IL‐17RA/(C/EBPβ)/SIRT1 pathway in a rat model of germinal matrix hemorrhage. This evidence concerns the gene IL17RA and Grade I preterm intraventricular hemorrhage.